Shares of CareTrust REIT, Inc. (NASDAQ:CTRE) have been given an average recommendation of “Buy” by the eleven brokerages that are currently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $19.38.

Several equities research analysts have recently weighed in on CTRE shares. KeyCorp reissued a “buy” rating and issued a $20.00 price objective on shares of CareTrust REIT in a report on Friday, August 25th. Capital One Financial Corporation started coverage on CareTrust REIT in a report on Monday, October 23rd. They issued an “equal weight” rating and a $21.00 price objective for the company. Zacks Investment Research raised CareTrust REIT from a “sell” rating to a “buy” rating and set a $21.00 price objective for the company in a report on Tuesday, October 24th. BidaskClub raised CareTrust REIT from a “hold” rating to a “buy” rating in a report on Saturday, August 19th. Finally, BMO Capital Markets reissued a “hold” rating and issued a $20.00 price objective on shares of CareTrust REIT in a report on Thursday, November 9th.

CareTrust REIT (NASDAQ:CTRE) traded down $0.20 during mid-day trading on Thursday, hitting $18.48. The stock had a trading volume of 451,400 shares, compared to its average volume of 541,050. The firm has a market capitalization of $1,420.00, a P/E ratio of 16.10, a P/E/G ratio of 3.98 and a beta of 0.72. CareTrust REIT has a 1-year low of $13.48 and a 1-year high of $19.86. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.60.

CareTrust REIT (NASDAQ:CTRE) last posted its quarterly earnings data on Wednesday, November 8th. The real estate investment trust reported $0.28 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.29 by ($0.01). The firm had revenue of $32.90 million during the quarter, compared to analyst estimates of $32.91 million. CareTrust REIT had a net margin of 25.68% and a return on equity of 5.76%. CareTrust REIT’s revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.28 earnings per share. equities research analysts expect that CareTrust REIT will post 1.17 EPS for the current fiscal year.

A number of institutional investors have recently added to or reduced their stakes in the business. LS Investment Advisors LLC lifted its holdings in CareTrust REIT by 2.0% in the second quarter. LS Investment Advisors LLC now owns 7,062 shares of the real estate investment trust’s stock valued at $131,000 after acquiring an additional 138 shares during the period. Navellier & Associates Inc lifted its holdings in CareTrust REIT by 1.0% in the second quarter. Navellier & Associates Inc now owns 41,831 shares of the real estate investment trust’s stock valued at $776,000 after acquiring an additional 421 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in CareTrust REIT by 7.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,277 shares of the real estate investment trust’s stock valued at $116,000 after acquiring an additional 437 shares during the period. Pinebridge Investments L.P. lifted its holdings in CareTrust REIT by 10.7% in the second quarter. Pinebridge Investments L.P. now owns 9,558 shares of the real estate investment trust’s stock valued at $177,000 after acquiring an additional 920 shares during the period. Finally, Ameritas Investment Partners Inc. lifted its holdings in CareTrust REIT by 18.2% in the second quarter. Ameritas Investment Partners Inc. now owns 6,329 shares of the real estate investment trust’s stock valued at $117,000 after acquiring an additional 975 shares during the period. 88.24% of the stock is owned by institutional investors.

WARNING: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/11/16/caretrust-reit-inc-ctre-given-consensus-recommendation-of-buy-by-brokerages.html.

CareTrust REIT Company Profile

CareTrust REIT, Inc is a self-administered, self-managed real estate investment trust. The Company is engaged in the ownership, acquisition and leasing of healthcare-related properties. It makes investments in healthcare-related real estate assets. As of December 31, 2016, its real estate portfolio included 154 skilled nursing facilities (SNFs), SNF Campuses, assisted living facilities and independent living facilities.

Analyst Recommendations for CareTrust REIT (NASDAQ:CTRE)

Receive News & Stock Ratings for CareTrust REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareTrust REIT Inc. and related stocks with our FREE daily email newsletter.